Health Condition 1: G952- Other and unspecified cord compression
Conditions
Interventions
Intervention1: Inj Buprenorphine: 300mcg, Diluted to 10ml Instilled into epidural space, 3 mins
Control Intervention1: Placebo (Normal saline): 10ml, instilled into epidural space, 3 mins
Sponsors
Department of Anaesthesiology
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to give informed and written consent ASA physical status I & II Patients with body weight 50-80kgs
Exclusion criteria
Exclusion criteria: ASA physical status III and above. Patients who have known hypersensitivity to the study drugs Patients with history of neuromuscular disease Patients with history of substance abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain by Numerical pain rating scale Timepoint: 1st, 2nd, 3rd, 4th, 5th, 6th, 12th, 18th and 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulse Rate Mean Arterial Pressure Respiratory Rate SpO2 Timepoint: 1st, 2nd, 3rd, 4th, 5th, 6th, 12th, 18th and 24 hours | — |
Countries
India
Contacts
Public ContactDr Amrutha H A
BGS Global Institute of Medical Sciences
Outcome results
None listed